Presented at ACMG 2024 by Genomenon’s Amina Kozaric, this study estimates the genetic prevalence of PLA2G6-associated neurodegeneration, which is an early onset progressive neurodegenerative disease.
We help provide insights into key genetic drivers of diseases and relevant biomarkers. By working together to understand this data, we enable scientists and researchers to make more informed decisions on programs of interest. To learn more about how we can partner together to find your genomic variant solutions, we invite you to click on the link below.